Comparison Corcept Therapeutics (CORT) with Competitors
Corcept Therapeutics (CORT) industry is Biotechnology.
Profit Margin
CORT-19.26%
Industry-0.77%
Upside-18.49%
Operating Margin
CORT-30.08%
Industry-2055.25%
Upside+2025.17%
Free Cash Flow Yield
CORT1.28%
Industry-1.75%
Upside+3.03%
P/E
CORT212.86
Industry-20.52
Upside+23337.32%
Forward P/E
CORT111.11
Industry16.33
Upside+580.39%
P/S
CORT12.63
Industry10.01
Upside+26.13%
P/B
CORT14.45
Industry5.15
Upside+180.76%